And while in most people with HIV traditional risk factors are driving their fatty liver disease, we do think there is a component of liver disease that is HIV specific, so some of those secondary effects of semaglutide may have unique benefits in people with HIV. Lake and colleagues enrolled 49 adults with MASLD and HIV into the open-label phase 2b SLIM LIVER study
SURMOUNT-1 results In this 72-week obesity trial, participants receiving tirzepatide achieved remarkable weight loss results: 5 mg dose: 85% achieved at least 5% weight reduction, with average weight loss of 15% 10 mg dose: 89% achieved at least 5% weight reduction, with average weight loss of 19% 15 mg dose: 91% achieved at least 5% weight reduction, with average weight loss of 21% These results were achieved with consistent weekly dosing
(34034086) Restricted diffusion may occur in the cortical ribbon, hippocampus, or thalamus (especially the pulvinar)
Allison Rhodes, M.D., a board-certified physician in internal medicine and obesity medicine at The Ohio State University Wexner Medical Center
These are usually mild and resolve spontaneously
Efficacy of Different Routes of Vitamin B12 Supplementation for the Treatment of Patients with Vitamin B12 Deficiency: A Systematic Review and Network Meta-Analysis. Irish Journal of Medical Science, 17 Jan